Publications by authors named "Maurizio Zangari"

100Publications

Monitoring Treatment Response and Disease Progression in Myeloma with Circulating Cell-Free DNA.

Eur J Haematol 2020 Oct 26. Epub 2020 Oct 26.

Division of Hematology Oncology, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13541DOI Listing
October 2020

Innate Biomineralization.

Int J Mol Sci 2020 Jul 8;21(14). Epub 2020 Jul 8.

Department of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms21144820DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404118PMC
July 2020

Primary Plasma Cell Neoplasm of the Kidney Without Formation of a Mass and Its Renal Manifestations: An Interstitial Variant of Renal Plasmacytoma?

Clin Lymphoma Myeloma Leuk 2020 Sep 16;20(9):e551-e555. Epub 2020 May 16.

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2020.05.007DOI Listing
September 2020

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Blood Adv 2020 01;4(1):181-190

Center for Genetic Epidemiology, Department of Preventive Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2019000491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960456PMC
January 2020

A Phase 1 Study of Intravenous Busulfan as a Conditioning Regimen for Multiple Myeloma.

Cell Transplant 2019 Dec 16;28(12):1624-1631. Epub 2019 Oct 16.

Division of Hematology and Hematological Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0963689719880541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923548PMC
December 2019

FRAX is a robust predictor of baseline vertebral fractures in multiple myeloma patients.

Bone 2019 04 19;121:134-138. Epub 2018 Sep 19.

Myeloma Institute for Research & Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, United States of America. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2018.09.013DOI Listing
April 2019

Visualizing collagen proteolysis by peptide hybridization: From 3D cell culture to in vivo imaging.

Biomaterials 2018 11 22;183:67-76. Epub 2018 Aug 22.

Department of Bioengineering, University of Utah, Salt Lake City, United States; Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biomaterials.2018.08.039DOI Listing
November 2018

Effect of low-dose bortezomib on bone formation in smouldering multiple myeloma.

Br J Haematol 2019 01 24;184(2):308-310. Epub 2018 Mar 24.

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15095DOI Listing
January 2019

Surgical thyroparathyroidectomy prevents progression of 5TGM1 murine multiple myeloma .

J Bone Oncol 2018 Sep 23;12:19-22. Epub 2018 Feb 23.

Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbo.2018.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854927PMC
September 2018

Thymic PTH Increases After Thyroparathyroidectomy in C57BL/KaLwRij Mice.

Endocrinology 2018 04;159(4):1561-1569

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2017-03083DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839736PMC
April 2018

The effects of proteasome inhibitors on bone remodeling in multiple myeloma.

Bone 2016 May 3;86:131-8. Epub 2016 Mar 3.

Department of Orthopedic Surgery, Center for Orthopaedic Research, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2016.02.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516941PMC
May 2016

Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?

Immunotherapy 2016 17;8(3):367-84. Epub 2016 Feb 17.

Myeloma Institute, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.15.118DOI Listing
December 2016

Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeutics.

Biomed Res Int 2015 27;2015:384575. Epub 2015 Apr 27.

State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin 300020, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/384575DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427090PMC
February 2016

Parathyroid hormone receptor mediates the anti-myeloma effect of proteasome inhibitors.

Bone 2014 Apr 31;61:39-43. Epub 2013 Dec 31.

Department of Orthopaedic Surgery, Center for Orthopaedic Research, University of Arkansas for Medical Sciences, Little Rock, AR, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2013.12.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967551PMC
April 2014

Mechanisms of thrombosis in paraproteinemias: the effects of immunomodulatory drugs.

Semin Thromb Hemost 2012 Nov 28;38(8):768-79. Epub 2012 Oct 28.

Myeloma Program, Division of Hematology, University of Utah, Salt Lake City, 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0032-1328888DOI Listing
November 2012

Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.

Biol Blood Marrow Transplant 2012 Nov 19;18(11):1753-8. Epub 2012 Jun 19.

Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2012.06.008DOI Listing
November 2012

Low-risk identification in multiple myeloma using a new 14-gene model.

Eur J Haematol 2012 Jul;89(1):28-36

Molecular Medicine Program, University of Utah, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2012.01792.xDOI Listing
July 2012

Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high-dose melphalan in patients with multiple myeloma.

Eur J Haematol 2012 Aug 31;89(2):145-50. Epub 2012 May 31.

Penn State Milton S. Hershey Cancer Institute, Hershey, PA 17033-0850, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2012.01795.xDOI Listing
August 2012

Impact of bortezomib on bone health in myeloma: a review of current evidence.

Cancer Treat Rev 2012 Dec 9;38(8):968-80. Epub 2012 Jan 9.

Stem Cell Transplant and Myeloma Program, University of Utah, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.12.007DOI Listing
December 2012

Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimens.

Clin Lymphoma Myeloma Leuk 2011 Apr 8;11(2):228-36. Epub 2011 Apr 8.

Blood/Marrow Transplant and Myeloma Program, Division of Hematology, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2011.03.006DOI Listing
April 2011

Progress in myeloma stem cells.

Am J Blood Res 2011 8;1(2):135-45. Epub 2011 Sep 8.

Division of Hematology, Blood/Marrow Transplant and Myeloma Program 30 N 1900 E, 5C417, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301427PMC
August 2012

Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma.

Clin Lymphoma Myeloma Leuk 2010 Dec;10(6):464-8

Penn State Hershey Cancer Institute, 500 University Drive, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLML.2010.n.080DOI Listing
December 2010

Multiple myeloma presenting as CEA-producing rectal cancer.

Rare Tumors 2010 Mar 31;2(1):e4. Epub 2010 Mar 31.

Penn State Hershey Cancer Institute, Hershey, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/rt.2010.e4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994484PMC
March 2010

Bone and paraproteinemias.

Curr Opin Support Palliat Care 2010 Sep;4(3):195-9

University of Utah School of Medicine, Salt Lake City, Utah 84132, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=01263393-201009000-000
Publisher Site
http://dx.doi.org/10.1097/SPC.0b013e32833d3011DOI Listing
September 2010

Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasone.

J Clin Oncol 2010 Jan 9;28(1):132-5. Epub 2009 Nov 9.

Division of Hematology, Blood/Marrow Transplant and Myeloma Program, 30 N 1900 E, 5C402, University of Utah, Salt Lake City, UT 84132, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.0169DOI Listing
January 2010

Evolving indications for hematopoietic stem cell transplantation in multiple myeloma and other plasma cell disorders.

Cancer Treat Res 2009 ;144:317-55

University of Utah School of Medicine, Salt Lake City, UT, USA. Guido.Tricot@ hsc.utah.edu

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-0-387-78580-6_14
Publisher Site
http://dx.doi.org/10.1007/978-0-387-78580-6_14DOI Listing
September 2010

Thrombotic events in patients with cancer receiving antiangiogenesis agents.

J Clin Oncol 2009 Oct 24;27(29):4865-73. Epub 2009 Aug 24.

University of Utah, Division of Hematology, Blood/Marrow Transplant and Myeloma Program, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2009.22.3875
Publisher Site
http://dx.doi.org/10.1200/JCO.2009.22.3875DOI Listing
October 2009

RARalpha2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma.

Blood 2009 Jul 20;114(3):600-7. Epub 2009 May 20.

The Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics at the Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W Markham, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-12-194126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713470PMC
July 2009

Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy.

Support Care Cancer 2010 Mar 21;18(3):301-5. Epub 2009 May 21.

Penn State Milton S. Hershey Cancer Institute, 500 University Dr, Hershey, PA 17033, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-009-0652-0DOI Listing
March 2010

Bleeding disorders associated with cancer dysproteinemias.

Cancer Treat Res 2009 ;148:295-304

University of Utah, Division of Hematology, Blood/Marrow Transplant and Myeloma Program, Salt Lake City, UT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-79962-9_17DOI Listing
October 2010

Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.

Blood Coagul Fibrinolysis 2009 Jul;20(5):337-9

Division of Hematology-Oncology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e32832b27e6DOI Listing
July 2009

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo.

Am J Hematol 2009 Jan;84(1):6-14

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2612734PMC
January 2009

The hemostatic system and malignancy.

Clin Lymphoma Myeloma 2008 Aug;8(4):230-6

Esoterix, Inc. Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2008.n.030DOI Listing
August 2008

Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.

Haematologica 2008 Nov 25;93(11):1739-42. Epub 2008 Aug 25.

University of Utah School of Medicine, 30N 1900E, 5C402,Salt Lake City, UT 84132 USA.

View Article

Download full-text PDF

Source
http://www.haematologica.org/cgi/doi/10.3324/haematol.13204
Publisher Site
http://dx.doi.org/10.3324/haematol.13204DOI Listing
November 2008

High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

Cancer 2008 Apr;112(8):1754-64

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652244PMC
April 2008

A practical guide to achieving and maintaining the best response to lenalidomide in multiple myeloma: roundtable proceedings.

Clin Adv Hematol Oncol 2007 Oct;5(10 Suppl 15):7-19, quiz 21-2

Hematology/Oncology Division, University of Pennsylvania Health System, Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA,

View Article

Download full-text PDF

Source
http://myeloma.org/pdfs/2007%20Cl%20Adv%20Hem%20Onc-%20A%20P
Web Search
October 2007

Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients.

Blood Coagul Fibrinolysis 2007 Oct;18(7):595-8

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MBC.0b013e3281067fb2DOI Listing
October 2007

Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients.

Am J Hematol 2007 Sep;82(9):831-3

The Myeloma Institute for Research and Therapy, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.20961DOI Listing
September 2007

Hemostatic dysfunction in paraproteinemias and amyloidosis.

Semin Thromb Hemost 2007 Jun;33(4):339-49

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2007-976169DOI Listing
June 2007

Thrombosis in multiple myeloma.

Expert Rev Anticancer Ther 2007 Mar;7(3):307-15

Myeloma Institute, University of Arkansas for Medical Sciences, 4301 W. Markham Street, Slot 776, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.7.3.307DOI Listing
March 2007

Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myeloma.

Curr Pharm Biotechnol 2006 Dec;7(6):449-53

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138920106779116838DOI Listing
December 2006

Anticoagulation regimens for thalidomide and lenalidomide.

Authors:
Maurizio Zangari

Clin Adv Hematol Oncol 2006 Sep;4(9):658-9

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
September 2006

Response to bortezomib and activation of osteoblasts in multiple myeloma.

Clin Lymphoma Myeloma 2006 Sep;7(2):109-14

University of Arkansas for Medical Sciences, Little Rock , AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.047DOI Listing
September 2006

Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis.

Blood 2007 Feb 5;109(4):1692-700. Epub 2006 Oct 5.

Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-07-037077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794073PMC
February 2007

Clinical and biological features of multiple myeloma involving the gastrointestinal system.

Haematologica 2006 Jul;91(7):964-7

Myeloma Institute for Research and Therapy, Division of Gastroenterology, The University of Arkansas for Medical Sciences, 4301 West Markham Street/Slot 776, Little Rock, Arkansas 72205, USA.

View Article

Download full-text PDF

Source
July 2006

Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.

Clin Lymphoma Myeloma 2006 May;6(6):469-74

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLM.2006.n.027DOI Listing
May 2006

The molecular classification of multiple myeloma.

Blood 2006 Sep 25;108(6):2020-8. Epub 2006 May 25.

Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-11-013458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895543PMC
September 2006

Inhibitory effects of osteoblasts and increased bone formation on myeloma in novel culture systems and a myelomatous mouse model.

Haematologica 2006 Feb;91(2):192-9

Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, 4301 W. Markham, Slot #776, Little Rock, AR 72205, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1592551PMC
February 2006